4baseCare revenue, valuation and funding
It has raised Rs 128 Cr in total, as reported by StopDown on 11 June 2026.
| Total raised | Rs 128 Cr |
|---|
Each figure links to the story that reported it.
4baseCare key facts
- What it doesGenomics-driven cancer diagnostics Story
- Founded2019 Profile
- Last roundRs 128 Cr, Series B, on 11 June 2026 Story
- StatusPrivate
Funding rounds
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 2024 | Series A | ₹50 crore | Yali Capital (lead) | Express Healthcare |
| Jan 2026 | Series B, first close | ₹90 crore | Ashish Kacholia (co-lead), Lashit Sanghvi (co-lead), Yali Capital | EntrackrExpress Healthcare |
| Jun 2026 | Series B, top-up | ₹38 crore | growX Ventures, Infosys, existing investors | Entrackr |
Timeline
- 2019
- 2019 Hitesh Goswami and Kshitij Rishi found 4baseCare Entrackr
- 2024
- 2024 Series A of about ₹50 crore, led by Yali Capital Express Healthcare
- 2026
- Jan 2026 First close of Series B: ₹90 crore, co-led by Ashish Kacholia and Lashit Sanghvi EntrackrExpress Healthcare
- Jun 2026 ₹38 crore top-up takes the Series B to ₹128 crore Entrackr
The short version
- 4baseCare is a precision oncology company that links genomic cancer tests with clinical data to guide treatment. Express HealthcareEntrackr
- Hitesh Goswami and Kshitij Rishi founded it in 2019; Goswami is the CEO. EntrackrExpress Healthcare
- In January 2026 it announced the first close of its Series B: ₹90 crore, co-led by Ashish Kacholia and Lashit Sanghvi, with existing investor Yali Capital taking part. EntrackrExpress Healthcare
- In June 2026 it added a ₹38 crore top-up to reach ₹128 crore for the Series B. Entrackr names growX Ventures and Infosys among the new money. Entrackr
- The money is for a network of hospital-linked genomics labs across India and overseas and for AI tools such as OncoTwin Insights that help doctors read treatment data. Express Healthcare
- Its Series A was about ₹50 crore in 2024, led by Yali Capital. Express Healthcare
Products
- OncoTwin: A platform that turns genomic and clinical data into treatment insights for oncologists. It was picked for the MSK iHub programme of Memorial Sloan Kettering in New York. Express Healthcare
People
- Hitesh Goswami: Co-founder and CEO of 4baseCare. Express HealthcareEntrackr
- Kshitij Rishi: Co-founder of 4baseCare. Entrackr
Questions people ask about 4baseCare
How much has 4baseCare raised?
4baseCare raised ₹128 crore (about $13.3 million) in its Series B by June 2026: ₹90 crore in the first close in January and a ₹38 crore top-up. It had earlier raised about ₹50 crore in a Series A in 2024, led by Yali Capital. EntrackrExpress Healthcare
Who founded 4baseCare?
Hitesh Goswami and Kshitij Rishi founded 4baseCare in 2019. Goswami is the chief executive. The company sells precision oncology services that join genomic testing with clinical data. EntrackrExpress Healthcare
Who invested in 4baseCare?
In the Series B, Ashish Kacholia and Lashit Sanghvi co-led the ₹90 crore first close in January 2026, with Yali Capital. The June 2026 top-up added growX Ventures and Infosys. Yali Capital led the ₹50 crore Series A in 2024. EntrackrEntrackrExpress Healthcare
What is 4baseCare's valuation?
No valuation for 4baseCare has been disclosed in the reports on its Series B. The company has not published a revenue or profit figure for a full financial year either, so no financial year numbers are listed here. Entrackr
Every line links to the article it came from, written in our own words. Not investment advice. Profile updated 2026-11-14.
Stories cover its funding and roundup news. Sectors: Healthcare & Life Sciences. Stages: Series-b. Stories run from 27 January 2026 to 11 June 2026.
The founders
Hitesh Goswami
Co-founder and CEOKshitij Rishi
Co-founderWho put in money
Every story on 4baseCare
- 4B
4baseCare · Funding · 11 June 2026 · Rs 128 Cr4baseCare raises Rs 128 Cr in Series B round4baseCare provides AI-led genomic cancer diagnostics through its OncoTwin platform - 4B
4baseCare · Roundup · 31 January 2026 · $9.8 Mn4baseCare raises $9.8 million in Series B4baseCare is a healthtech and lifescience company serving businesses - 4B
4baseCare · Funding · 27 January 2026 · ₹90 crore4baseCare raises ₹90 crore in Series B4baseCare is a precision oncology company that integrates genomic testing with clinical data
Read next on 4baseCare
For 4baseCare: add the “Featured on StopDown” badge
Put this on your website's press or media page. It links readers to 4baseCare on StopDown.

